Frankrike - fransk - ANSES (Agence nationale de sécurité sanitaire de l’alimentation, de l’environnement et du travail)

vmd - lévamisole (sous forme de chlorhydrate) - poudre pour administration dans l'eau de boisson - anthelminthiques, imidazothiazoles - porcins

Frankrike - fransk - ANSES (Agence nationale de sécurité sanitaire de l’alimentation, de l’environnement et du travail)

vmd - acide salicylique (sous forme de sel de sodium) - poudre pour administration dans l'eau de boisson ou le lait

Frankrike - fransk - ANSES (Agence nationale de sécurité sanitaire de l’alimentation, de l’environnement et du travail)

vmd - chlorhydrate d'amprolium - solution pour administration dans l'eau de boisson

Den europeiske union - latvisk - EMA (European Medicines Agency)

pharmaswiss ceska republika s.r.o - pegaptanib - wet macular degeneration - oftalmoloģiskie līdzekļi - macugen ir indicēts neovaskulārai (mitrai) ar vecumu saistītā makulas deģenerācijai (amd).

Hellas - gresk - Εθνικός Οργανισμός Φαρμάκων

nutri-biomed ΕΛΛΑΣ ΕΠΕ (0000008003) Β. Ουγκώ 1 & Χλόης 98,,144 52,144 52, Μεταμόρφωση,gr - ΘΕΙΙΚΉ ΚΟΛΙΣΤΊΝΗ - ΚΟΝΙΣ ΓΙΑ ΠΟΣΙΜΟ ΔΙΑΛΥΜΑ - colistin sulfate 40,00 pd.ora.sol - colistin - colistin - Χρόνοι αναμονής:

Hellas - gresk - Εθνικός Οργανισμός Φαρμάκων

nutri-biomed ΕΛΛΑΣ ΕΠΕ (0000008003) Β. Ουγκώ 1 & Χλόης 98,,144 52,144 52, Μεταμόρφωση,gr - doxycycline hyclate - ΚΟΝΙΣ ΓΙΑ ΠΟΣΙΜΟ ΔΙΑΛΥΜΑ - 500mg/g - doxycycline hyclate 500,00 pd.ora.sol 500mg/g - doxycycline - Μόσχοι; Ορνιθοειδή; Χοιρίδια - Χρόνοι αναμονής: Μόσχοι 14; Ορνιθοειδή 9; Χοιρίδια 8

Den europeiske union - islandsk - EMA (European Medicines Agency)

vmd n.v. - túlatrómýsín - antibacterials for systemic use, macrolides - cattle; pigs; sheep - cattle: treatment and metaphylaxis of bovine respiratory disease (brd) associated with mannheimia haemolytica, pasteurella multocida, histophilus somni and mycoplasma bovis susceptible to tulathromycin. tilvist sjúkdómsins í hjörðinni skal komið á áður en meðferð með bráðaofnæmi. treatment of infectious bovine keratoconjunctivitis (ibk) associated with moraxella bovis susceptible to tulathromycin. pigs: treatment and metaphylaxis of swine respiratory disease (srd) associated with actinobacillus pleuropneumoniae, pasteurella multocida, mycoplasma hyopneumoniae, haemophilus parasuis and bordetella bronchiseptica susceptible to tulathromycin. tilvist sjúkdómsins í hjörðinni skal komið á áður en meðferð með bráðaofnæmi. the product should only be used if pigs are expected to develop the disease within 2–3 days. sauðfé: meðferð á fyrstu stigum smitandi beinbólgu (fótspyrnu) í tengslum við veirufræðilega dichelobacter nodosus sem krefst kerfisbundinnar meðferðar.

Den europeiske union - maltesisk - EMA (European Medicines Agency)

vmd n.v. - tulathromycin - antibacterials for systemic use, macrolides - cattle; pigs; sheep - cattle: treatment and metaphylaxis of bovine respiratory disease (brd) associated with mannheimia haemolytica, pasteurella multocida, histophilus somni and mycoplasma bovis susceptible to tulathromycin. il-preżenza tal-marda fil-merħla għandha tiġi stabbilita qabel it-trattament metaphylactic. treatment of infectious bovine keratoconjunctivitis (ibk) associated with moraxella bovis susceptible to tulathromycin. pigs: treatment and metaphylaxis of swine respiratory disease (srd) associated with actinobacillus pleuropneumoniae, pasteurella multocida, mycoplasma hyopneumoniae, haemophilus parasuis and bordetella bronchiseptica susceptible to tulathromycin. il-preżenza tal-marda fil-merħla għandha tiġi stabbilita qabel it-trattament metaphylactic. the product should only be used if pigs are expected to develop the disease within 2–3 days. nagħaġ: trattament tal-istadji bikrija ta 'pododermatite infettiva (taħsir tas-sieq) assoċjat ma' dichelobacter nodosus virulenti li jeħtieġ trattament sistemiku.

Den europeiske union - norsk - EMA (European Medicines Agency)

vmd n.v. - tulathromycin - antibacterials for systemic use, macrolides - cattle; pigs; sheep - cattle: treatment and metaphylaxis of bovine respiratory disease (brd) associated with mannheimia haemolytica, pasteurella multocida, histophilus somni and mycoplasma bovis susceptible to tulathromycin. tilstedeværelsen av sykdommen i flokken bør etableres før metafylaktisk behandling. treatment of infectious bovine keratoconjunctivitis (ibk) associated with moraxella bovis susceptible to tulathromycin. pigs: treatment and metaphylaxis of swine respiratory disease (srd) associated with actinobacillus pleuropneumoniae, pasteurella multocida, mycoplasma hyopneumoniae, haemophilus parasuis and bordetella bronchiseptica susceptible to tulathromycin. tilstedeværelsen av sykdommen i flokken bør etableres før metafylaktisk behandling. the product should only be used if pigs are expected to develop the disease within 2–3 days. sau: behandling av de tidlige stadier av infeksjonell pododermatitt (fotrot) assosiert med virulent dichelobacter nodosus som krever systemisk behandling.

Den europeiske union - slovensk - EMA (European Medicines Agency)

vmd n.v. - tulatromicin - antibacterials for systemic use, macrolides - cattle; pigs; sheep - cattle: treatment and metaphylaxis of bovine respiratory disease (brd) associated with mannheimia haemolytica, pasteurella multocida, histophilus somni and mycoplasma bovis susceptible to tulathromycin. prisotnost bolezni v čredi je treba določiti pred metafilaktičnim zdravljenjem. treatment of infectious bovine keratoconjunctivitis (ibk) associated with moraxella bovis susceptible to tulathromycin. pigs: treatment and metaphylaxis of swine respiratory disease (srd) associated with actinobacillus pleuropneumoniae, pasteurella multocida, mycoplasma hyopneumoniae, haemophilus parasuis and bordetella bronchiseptica susceptible to tulathromycin. prisotnost bolezni v čredi je treba določiti pred metafilaktičnim zdravljenjem. the product should only be used if pigs are expected to develop the disease within 2–3 days. ovce: zdravljenje zgodnjih fazah nalezljivih pododermatitis (stopala gnilobe), ki je povezana s sovražno dichelobacter nodosus, ki zahteva sistemsko zdravljenje.